Duplisea, Jonathan J.
Mokkapati, Sharada
Plote, Devin
Schluns, Kimberly S.
McConkey, David J.
Yla-Herttuala, Seppo
Parker, Nigel R.
Dinney, Colin P.
Funding for this research was provided by:
National Cancer Institute (P50CA091846)
National Institutes of Health (P30CA016672)
Article History
Received: 5 August 2018
Accepted: 29 October 2018
First Online: 11 November 2018
Compliance with ethical standards
:
: Nigel Parker: leadership, consulting, and research funding—FKD Therapies Oy. Seppo Yla-Herttulla: consultant for FKD Therapies Oy. Colin Dinney: consultant on advisory board for FKD Therapies Oy. All remaining authors declare no conflicts of interest.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
: Informed consent was obtained from all individual participants of clinical studies included in this review article.